:@0.914624:0.081813:0.920519:0.081813:0.920519:0.063369:0.914624:0.063369:0.005895
 :@0.884977:0.970453:0.890322:0.970453:0.890322:0.952432:0.884977:0.952432:0.005345
OT16  Andrographolide induced Apoptosis and Cell Cycle :@0.242066:0.104825:0.856340:0.104825:0.856340:0.086058:0.242066:0.086058:0.018529:0.014554:0.013245:0.013108:0.006617:0.006781:0.015876:0.013234:0.013234:0.007926:0.013163:0.013234:0.007974:0.013115:0.013234:0.013234:0.013234:0.005189:0.005284:0.013234:0.013234:0.006617:0.005284:0.013234:0.013234:0.013115:0.011901:0.013306:0.013234:0.006617:0.015638:0.013234:0.013234:0.013234:0.006617:0.013115:0.011901:0.005284:0.012020:0.006617:0.013044:0.013234:0.013234:0.006450:0.017185:0.013282:0.005284:0.005284:0.006546:0.017114:0.011901:0.011901:0.005284:0.013234:0.006617
 :@0.242066:0.125687:0.248683:0.125687:0.248683:0.106920:0.242066:0.106920:0.006617
Arrest in MDA-MB-231 and MCF-7 Breast Cancer :@0.314899:0.125687:0.844474:0.125687:0.844474:0.106920:0.314899:0.106920:0.015876:0.007926:0.007926:0.013234:0.011901:0.006617:0.006498:0.005284:0.013234:0.006617:0.019828:0.017043:0.015819:0.007982:0.019812:0.015868:0.007982:0.013234:0.013139:0.013234:0.006617:0.013234:0.013092:0.013234:0.006617:0.019828:0.017185:0.014399:0.007982:0.013234:0.006617:0.015781:0.007926:0.013234:0.013234:0.011901:0.006617:0.006522:0.017185:0.013234:0.013234:0.011782:0.013234:0.007974:0.006617
Cells :@0.314899:0.146584:0.374253:0.146584:0.374253:0.127817:0.314899:0.127817:0.017185:0.013282:0.005284:0.005118:0.011867:0.006617
 :@0.906214:0.104825:0.912832:0.104825:0.912832:0.086058:0.906214:0.086058:0.006617
OT17  The Protective Effect of THICAPA on Familial :@0.242066:0.173292:0.799547:0.173292:0.799547:0.154525:0.242066:0.154525:0.018529:0.014554:0.013245:0.013108:0.006617:0.006781:0.014543:0.013234:0.013234:0.006617:0.015805:0.007926:0.013282:0.006617:0.013044:0.011901:0.006617:0.005284:0.011901:0.013234:0.006498:0.015876:0.006498:0.006617:0.013234:0.011901:0.006617:0.006522:0.013234:0.006617:0.006522:0.014543:0.017185:0.006617:0.017185:0.015876:0.015876:0.015757:0.006617:0.013234:0.013234:0.006546:0.014543:0.013234:0.019828:0.005284:0.005284:0.005284:0.013234:0.005284:0.006617
 :@0.242066:0.194155:0.248683:0.194155:0.248683:0.175388:0.242066:0.175388:0.006617
Alzheimer's Disease Pathogenesis Using Skin-derived :@0.314899:0.194155:0.892700:0.194155:0.892700:0.175388:0.314899:0.175388:0.015876:0.005284:0.011901:0.013234:0.013234:0.005284:0.019709:0.013234:0.007974:0.004427:0.011901:0.006617:0.017185:0.005213:0.011901:0.013306:0.013115:0.011901:0.013306:0.006617:0.015757:0.013234:0.006617:0.013234:0.013092:0.013234:0.013234:0.013234:0.013234:0.011901:0.005141:0.011901:0.006617:0.017185:0.011901:0.005284:0.013092:0.013234:0.006617:0.015781:0.011901:0.005284:0.013430:0.007839:0.013234:0.013234:0.007998:0.005141:0.011901:0.013234:0.013234:0.006617
Fibroblast Cell Lines  :@0.314899:0.214917:0.543343:0.214917:0.543343:0.196150:0.314899:0.196150:0.014543:0.005284:0.013234:0.007926:0.013234:0.013234:0.005284:0.013068:0.011901:0.006617:0.006617:0.017185:0.013115:0.005284:0.005284:0.006546:0.013234:0.005284:0.013234:0.013234:0.011997:0.006483:0.006617
 :@0.906214:0.173292:0.912832:0.173292:0.912832:0.154525:0.906214:0.154525:0.006617
Poster Presenter :@0.242066:0.244447:0.438820:0.244447:0.438820:0.225680:0.242066:0.225680:0.015876:0.014543:0.013234:0.007926:0.013234:0.009259:0.006617:0.015805:0.009259:0.013115:0.013234:0.013139:0.014543:0.007926:0.013234:0.009189:0.006617
P-1 :@0.242066:0.273977:0.285599:0.273977:0.285599:0.255210:0.242066:0.255210:0.015821:0.007982:0.013113:0.006617
Comparative genomic analysis of a :@0.314899:0.273977:0.691102:0.273977:0.691102:0.255210:0.314899:0.255210:0.017185:0.013282:0.019828:0.013092:0.013234:0.007926:0.013234:0.006522:0.005284:0.011901:0.013282:0.006403:0.013234:0.013234:0.013234:0.013306:0.019828:0.005118:0.011901:0.006617:0.013234:0.013139:0.013234:0.005141:0.011901:0.012020:0.005141:0.011901:0.006617:0.013234:0.006617:0.006522:0.013234:0.006617
Mycobacterium :@0.691230:0.273944:0.858896:0.273944:0.858896:0.255210:0.691230:0.255210:0.019828:0.011806:0.011901:0.013234:0.013234:0.013092:0.011901:0.006617:0.013234:0.007998:0.005284:0.013092:0.019828:0.006617
tuberculosis :@0.314899:0.294806:0.448266:0.294806:0.448266:0.276073:0.314899:0.276073:0.006617:0.013234:0.013234:0.013234:0.007831:0.011901:0.013306:0.005284:0.013092:0.011901:0.005213:0.011901:0.006617
STB-T6A strain isolated from spinal :@0.448309:0.294840:0.828616:0.294840:0.828616:0.276073:0.448309:0.276073:0.015876:0.014543:0.015760:0.007982:0.014543:0.013234:0.015876:0.006522:0.011901:0.006617:0.007855:0.013115:0.005284:0.013234:0.006617:0.005284:0.011901:0.013234:0.005284:0.013234:0.006617:0.013092:0.013234:0.006617:0.006522:0.007926:0.013234:0.019756:0.006617:0.011901:0.013234:0.005284:0.013234:0.013234:0.005284:0.006617
epidural mass in Sabah, Malaysia :@0.314899:0.315703:0.676752:0.315703:0.676752:0.296936:0.314899:0.296936:0.013234:0.013234:0.005284:0.013234:0.013234:0.007926:0.013234:0.005284:0.006617:0.019756:0.013115:0.011901:0.011901:0.006617:0.005284:0.013234:0.006498:0.015876:0.013234:0.013234:0.013234:0.013234:0.006617:0.006522:0.019661:0.013234:0.005284:0.013234:0.011901:0.011901:0.005284:0.013190:0.006617
 :@0.906214:0.273977:0.912832:0.273977:0.912832:0.255210:0.906214:0.255210:0.006617
P-2 :@0.242066:0.342411:0.285599:0.342411:0.285599:0.323644:0.242066:0.323644:0.015821:0.007982:0.013113:0.006617
Biomarkers in Endothelial Dysfunction-associated :@0.314899:0.342411:0.843218:0.342411:0.843218:0.323644:0.314899:0.323644:0.015876:0.005284:0.013234:0.019828:0.013234:0.007807:0.011901:0.013234:0.007926:0.011949:0.006617:0.005284:0.013044:0.006617:0.015757:0.013234:0.013234:0.013234:0.006617:0.013234:0.013234:0.005284:0.005284:0.013234:0.005284:0.006450:0.017185:0.011901:0.011901:0.006617:0.013234:0.013139:0.011901:0.006617:0.005284:0.013234:0.013196:0.007982:0.013115:0.011901:0.011901:0.013234:0.011973:0.005141:0.013234:0.006617:0.013234:0.013234:0.006617
Type 2 Diabetes Mellitus :@0.314899:0.363274:0.581684:0.363274:0.581684:0.344507:0.314899:0.344507:0.014543:0.011901:0.013306:0.013234:0.006617:0.013234:0.006403:0.017185:0.005284:0.013234:0.013234:0.013068:0.006617:0.013234:0.011901:0.006617:0.019828:0.013234:0.005284:0.005284:0.005284:0.006498:0.013234:0.011905:0.006617
 :@0.906214:0.342411:0.912832:0.342411:0.912832:0.323644:0.906214:0.323644:0.006617
P-3 :@0.242066:0.389982:0.285599:0.389982:0.285599:0.371215:0.242066:0.371215:0.015821:0.007982:0.013113:0.006617
Alterations of tissue inhibitor of metalloproteinase :@0.314899:0.389982:0.839321:0.389982:0.839321:0.371215:0.314899:0.371215:0.015876:0.005284:0.006498:0.013234:0.007974:0.013234:0.006617:0.005284:0.013234:0.013092:0.011901:0.006617:0.013234:0.006617:0.006522:0.006617:0.005284:0.011901:0.011901:0.013234:0.013234:0.006522:0.005284:0.013234:0.013234:0.005284:0.013234:0.005284:0.006617:0.013092:0.007926:0.006617:0.013234:0.006617:0.006522:0.019828:0.013234:0.006617:0.013234:0.005284:0.005284:0.013234:0.013234:0.007831:0.013234:0.006617:0.013234:0.005284:0.013234:0.013115:0.011901:0.013306:0.006617
levels among smokers with coronary artery disease :@0.314899:0.410879:0.861663:0.410879:0.861663:0.392112:0.314899:0.392112:0.005284:0.013234:0.011949:0.013234:0.005141:0.011901:0.006617:0.013234:0.019828:0.013139:0.013234:0.013139:0.006617:0.011901:0.019828:0.013115:0.011901:0.013306:0.007831:0.011901:0.006617:0.017185:0.005284:0.006617:0.013115:0.006617:0.011901:0.013234:0.007998:0.013115:0.013234:0.013139:0.007926:0.011997:0.006617:0.013044:0.007926:0.006617:0.013234:0.007926:0.012020:0.006617:0.013234:0.005094:0.011901:0.013234:0.013234:0.011806:0.013320:0.006617
 :@0.906214:0.389982:0.912832:0.389982:0.912832:0.371215:0.906214:0.371215:0.006617
P-4 :@0.242066:0.437587:0.285599:0.437587:0.285599:0.418820:0.242066:0.418820:0.015821:0.007982:0.013113:0.006617
The influence of receptor modulation in neurogenic :@0.314899:0.437587:0.856293:0.437587:0.856293:0.418820:0.314899:0.418820:0.014543:0.013234:0.013234:0.006617:0.005284:0.013234:0.006546:0.005284:0.013234:0.013234:0.013139:0.011901:0.013234:0.006498:0.013234:0.006617:0.006522:0.007926:0.013282:0.011901:0.013234:0.013234:0.006522:0.013234:0.007974:0.006403:0.019828:0.013234:0.013234:0.013234:0.005284:0.013234:0.006617:0.005284:0.013092:0.013234:0.006617:0.005284:0.013068:0.006617:0.013234:0.013234:0.013234:0.007926:0.013234:0.013234:0.013234:0.013234:0.005141:0.011901:0.006617
niche of LPC-induced demyelinated postnatal spinal :@0.314899:0.458450:0.868168:0.458450:0.868168:0.439683:0.314899:0.439683:0.013234:0.005284:0.011949:0.013115:0.013234:0.006617:0.013234:0.006546:0.006617:0.013234:0.015781:0.017270:0.007839:0.005284:0.013234:0.013234:0.013139:0.011901:0.013306:0.013234:0.006617:0.013068:0.013234:0.019685:0.011901:0.013306:0.005284:0.005284:0.013092:0.013234:0.006617:0.013234:0.013234:0.006617:0.013234:0.013068:0.011901:0.006474:0.013234:0.013234:0.006617:0.013234:0.005284:0.006617:0.011901:0.013234:0.005284:0.013115:0.013234:0.005284:0.006617
cord   :@0.314899:0.479312:0.380952:0.479312:0.380952:0.460545:0.314899:0.460545:0.011901:0.013306:0.007831:0.013234:0.006617:0.006546:0.006617
 :@0.906214:0.437587:0.912832:0.437587:0.912832:0.418820:0.906214:0.418820:0.006617
P-5 :@0.242066:0.506021:0.285599:0.506021:0.285599:0.487254:0.242066:0.487254:0.015821:0.007982:0.013113:0.006617
Polymeric nanowires as 3D scaffold for cellular :@0.314899:0.506021:0.813971:0.506021:0.813971:0.487254:0.314899:0.487254:0.015876:0.013234:0.005284:0.011901:0.019828:0.013115:0.007926:0.005284:0.011997:0.006617:0.013044:0.013115:0.013234:0.013234:0.017257:0.005141:0.007926:0.013234:0.011901:0.006617:0.013234:0.011901:0.006617:0.013092:0.017185:0.006617:0.011901:0.011901:0.013234:0.006617:0.006522:0.013234:0.005284:0.013234:0.006617:0.006522:0.013234:0.007926:0.006498:0.011901:0.013306:0.005284:0.005284:0.013234:0.005284:0.013092:0.007926:0.006617
cultivation intended for downstream biomarker or :@0.314899:0.526883:0.835132:0.526883:0.835132:0.508116:0.314899:0.508116:0.011901:0.013306:0.005284:0.006617:0.005213:0.011901:0.013234:0.006498:0.005284:0.013234:0.013234:0.006617:0.005284:0.013234:0.006403:0.013234:0.013234:0.013234:0.013234:0.013234:0.006522:0.006617:0.013234:0.007926:0.006617:0.013234:0.013092:0.017185:0.013234:0.011901:0.006617:0.007926:0.013234:0.013139:0.019828:0.006546:0.013234:0.005284:0.013115:0.019828:0.013234:0.007855:0.011901:0.013306:0.007926:0.006617:0.013115:0.007926:0.006617
molecular diagnostic applications :@0.314899:0.547746:0.670196:0.547746:0.670196:0.528979:0.314899:0.528979:0.019828:0.013234:0.005284:0.013234:0.011901:0.013234:0.005284:0.013068:0.007926:0.006617:0.013234:0.005284:0.013115:0.013234:0.013234:0.013163:0.011901:0.006617:0.005284:0.011901:0.006617:0.013234:0.013139:0.013234:0.005284:0.005284:0.011901:0.013234:0.006498:0.005284:0.013234:0.013234:0.011918:0.006617
 :@0.906214:0.506021:0.912832:0.506021:0.912832:0.487254:0.906214:0.487254:0.006617
P-6 :@0.242066:0.574454:0.285599:0.574454:0.285599:0.555688:0.242066:0.555688:0.015821:0.007982:0.013113:0.006617
Identification of a novel variant in a proximal :@0.314899:0.574454:0.783742:0.574454:0.783742:0.555688:0.314899:0.555688:0.006617:0.013234:0.013234:0.013234:0.006617:0.005284:0.006498:0.005284:0.011901:0.013282:0.006617:0.005284:0.013234:0.013234:0.006379:0.013234:0.006617:0.006522:0.013234:0.006617:0.013234:0.013234:0.011949:0.013234:0.005284:0.006522:0.011901:0.013306:0.007831:0.005284:0.013234:0.013234:0.006617:0.006522:0.005284:0.013234:0.006617:0.013234:0.006522:0.013234:0.007974:0.013115:0.011901:0.005213:0.019828:0.013234:0.005284:0.006617
symphalangism family by whole-exome sequencing :@0.314899:0.595317:0.862803:0.595317:0.862803:0.576550:0.314899:0.576550:0.011901:0.011901:0.019828:0.013234:0.013234:0.013234:0.005189:0.013234:0.013234:0.013234:0.005189:0.011901:0.019733:0.006617:0.006498:0.013234:0.019828:0.005284:0.005284:0.011901:0.006617:0.013234:0.011973:0.006403:0.017114:0.013234:0.013234:0.005284:0.013352:0.007839:0.013234:0.011901:0.013234:0.019828:0.013234:0.006379:0.011901:0.013234:0.013234:0.013234:0.013115:0.013234:0.011973:0.005141:0.013234:0.013193:0.006617
 :@0.906214:0.574454:0.912832:0.574454:0.912832:0.555688:0.906214:0.555688:0.006617
P-7 :@0.242066:0.622025:0.285599:0.622025:0.285599:0.603259:0.242066:0.603259:0.015821:0.007982:0.013113:0.006617
Multiplex PCR assay for simultaneous detection of :@0.314899:0.622025:0.851008:0.622025:0.851008:0.603259:0.314899:0.603259:0.019828:0.013234:0.005284:0.006617:0.005213:0.013234:0.005284:0.013234:0.011973:0.006617:0.015615:0.017114:0.017185:0.006617:0.013234:0.011901:0.011901:0.013139:0.011901:0.006617:0.006617:0.013234:0.007926:0.006450:0.011901:0.005213:0.019828:0.013234:0.005284:0.006617:0.013234:0.013234:0.013234:0.013115:0.013234:0.011973:0.006617:0.013044:0.013234:0.006617:0.013234:0.011901:0.006617:0.005284:0.013234:0.013234:0.006617:0.013234:0.006546:0.006617
Vibrio parahaemolyticus  Vibrio alginolyticus :@0.314899:0.642888:0.784933:0.642888:0.784933:0.624121:0.314899:0.624121:0.015876:0.005284:0.013234:0.007926:0.005284:0.013234:0.006617:0.013234:0.013092:0.007926:0.013282:0.013115:0.013115:0.013234:0.019828:0.013234:0.005284:0.011973:0.006617:0.005070:0.011901:0.013234:0.011901:0.006617:0.006522:0.015876:0.005284:0.013234:0.007926:0.005284:0.013234:0.006617:0.013234:0.005284:0.013234:0.005118:0.013234:0.013234:0.005165:0.011901:0.006617:0.005284:0.011901:0.013234:0.011879:0.006617
 :@0.906214:0.622025:0.912832:0.622025:0.912832:0.603259:0.906214:0.603259:0.006617
P-8 :@0.242066:0.669597:0.285599:0.669597:0.285599:0.650830:0.242066:0.650830:0.015821:0.007982:0.013113:0.006617
Development and comparison of primers for rapid :@0.314899:0.669597:0.843106:0.669597:0.843106:0.650830:0.314899:0.650830:0.017185:0.013234:0.011901:0.013234:0.005284:0.013139:0.013234:0.019828:0.013234:0.013234:0.006450:0.006617:0.013234:0.013234:0.013234:0.006617:0.011901:0.013234:0.019709:0.013234:0.013139:0.007926:0.005189:0.011901:0.013306:0.013234:0.006617:0.013234:0.006546:0.006617:0.013044:0.007926:0.005284:0.019828:0.013234:0.007926:0.011901:0.006617:0.006522:0.013234:0.007974:0.006617:0.007926:0.013115:0.013234:0.005284:0.013234:0.006617
detection of :@0.314899:0.690493:0.444362:0.690493:0.444362:0.671726:0.314899:0.671726:0.013234:0.013234:0.006617:0.013234:0.011949:0.006617:0.005284:0.013044:0.013234:0.006617:0.013234:0.006546:0.006617
Leptospira :@0.444318:0.690459:0.562070:0.690459:0.562070:0.671726:0.444318:0.671726:0.013234:0.013234:0.013234:0.006617:0.013234:0.011901:0.013234:0.005284:0.007926:0.013234:0.006617
spp. using polymerase chain :@0.561954:0.690493:0.869723:0.690493:0.869723:0.671726:0.561954:0.671726:0.011901:0.013306:0.013115:0.006617:0.006498:0.013234:0.011973:0.005284:0.013234:0.013234:0.006617:0.013234:0.013234:0.005141:0.011901:0.019733:0.013234:0.007974:0.013115:0.011901:0.013306:0.006617:0.011759:0.013234:0.013234:0.005284:0.013234:0.006617
reaction :@0.314899:0.711255:0.406038:0.711255:0.406038:0.692488:0.314899:0.692488:0.007926:0.013282:0.013115:0.011901:0.006617:0.005284:0.013234:0.013160:0.006617
 :@0.906214:0.669597:0.912832:0.669597:0.912832:0.650830:0.906214:0.650830:0.006617
P-9 :@0.242066:0.738064:0.285599:0.738064:0.285599:0.719297:0.242066:0.719297:0.015821:0.007982:0.013113:0.006617
Enhancing Molecular Diagnostic Testing for :@0.314899:0.738064:0.779838:0.738064:0.779838:0.719297:0.314899:0.719297:0.015876:0.013234:0.013234:0.013234:0.013115:0.011901:0.005284:0.013282:0.013234:0.006617:0.019637:0.013234:0.005284:0.013234:0.011901:0.013234:0.005284:0.013234:0.007926:0.006450:0.017185:0.005284:0.013234:0.013234:0.013234:0.013234:0.011901:0.006617:0.005141:0.011901:0.006617:0.014543:0.013115:0.011901:0.006617:0.005284:0.013234:0.013234:0.006617:0.006546:0.013234:0.007974:0.006617
Leptospirosis: Role of External Quality Assurance :@0.314899:0.758826:0.842987:0.758826:0.842987:0.740059:0.314899:0.740059:0.013234:0.013234:0.013234:0.006617:0.013115:0.011901:0.013306:0.005284:0.007831:0.013234:0.011973:0.005141:0.011901:0.006474:0.006617:0.017185:0.013234:0.005284:0.013234:0.006617:0.013234:0.006617:0.006498:0.015876:0.011901:0.006617:0.013068:0.007926:0.013282:0.013234:0.005284:0.006617:0.018519:0.013068:0.013234:0.005284:0.005284:0.006617:0.011901:0.006617:0.015638:0.011901:0.011901:0.013234:0.007974:0.013115:0.013234:0.011901:0.013234:0.006617
(EQA) Program In Referral Laboratories :@0.314899:0.779689:0.741176:0.779689:0.741176:0.760922:0.314899:0.760922:0.007926:0.015876:0.018519:0.015876:0.007926:0.006617:0.015781:0.007926:0.013234:0.013234:0.007783:0.013115:0.019828:0.006546:0.006617:0.013234:0.006522:0.017185:0.013282:0.006617:0.013234:0.007807:0.007926:0.013282:0.005284:0.006403:0.013234:0.013234:0.013234:0.013234:0.007926:0.013234:0.006617:0.013068:0.007926:0.005284:0.013163:0.011919:0.006617
 :@0.906214:0.738064:0.912832:0.738064:0.912832:0.719297:0.906214:0.719297:0.006617
P-10  Application of Median Nerve Electrical Stimulation to :@0.242066:0.806397:0.872145:0.806397:0.872145:0.787630:0.242066:0.787630:0.015821:0.007982:0.013255:0.013113:0.006617:0.016045:0.015876:0.013234:0.013234:0.005284:0.005284:0.011901:0.013234:0.006617:0.005284:0.013092:0.013234:0.006617:0.013234:0.006546:0.006617:0.019756:0.013234:0.013234:0.005284:0.013234:0.013282:0.006617:0.017043:0.013234:0.007926:0.011759:0.013234:0.006617:0.015781:0.005284:0.013234:0.011949:0.006617:0.007926:0.005118:0.011901:0.013306:0.005284:0.006617:0.015757:0.006617:0.005284:0.019733:0.013234:0.005284:0.013234:0.006617:0.005284:0.013234:0.013234:0.006617:0.006498:0.013234:0.006617
Regulate miR-1-3p in the BDNF/TrkB-MAPK Pathway :@0.314899:0.827260:0.886697:0.827260:0.886697:0.808493:0.314899:0.808493:0.017185:0.013282:0.013115:0.013234:0.005284:0.013234:0.006617:0.013234:0.006617:0.019733:0.005284:0.017136:0.007982:0.013255:0.007839:0.013234:0.013234:0.006617:0.005284:0.013234:0.006617:0.006498:0.013234:0.013234:0.006617:0.015805:0.017185:0.017281:0.014543:0.006617:0.014329:0.007831:0.011901:0.015962:0.007982:0.019661:0.015876:0.015757:0.015876:0.006498:0.015876:0.013234:0.006522:0.013234:0.017233:0.013234:0.011901:0.006617
for Promoting Myelin Regeneration in a Rat Stroke :@0.314899:0.848122:0.852413:0.848122:0.852413:0.829355:0.314899:0.829355:0.006617:0.013234:0.007926:0.006617:0.015781:0.007926:0.013282:0.019828:0.013234:0.006617:0.005284:0.013044:0.013115:0.006617:0.019756:0.011901:0.013306:0.005284:0.005284:0.013234:0.006617:0.017043:0.013234:0.013234:0.013163:0.013234:0.013234:0.007998:0.013234:0.006617:0.005284:0.013068:0.013234:0.006617:0.005284:0.013234:0.006522:0.013234:0.006617:0.017185:0.013234:0.006617:0.006546:0.015876:0.006498:0.007926:0.013282:0.011901:0.013234:0.006617
Model :@0.314899:0.868985:0.386226:0.868985:0.386226:0.850218:0.314899:0.850218:0.019828:0.013234:0.013234:0.013234:0.005179:0.006617
 :@0.906214:0.806397:0.912832:0.806397:0.912832:0.787630:0.906214:0.787630:0.006617
P-11  Autoantibodies profile in paraneoplastic neurological :@0.242066:0.895693:0.870931:0.895693:0.870931:0.876927:0.242066:0.876927:0.015821:0.007982:0.013255:0.013113:0.006617:0.016045:0.015876:0.013234:0.006522:0.013234:0.013234:0.013234:0.006617:0.005284:0.013234:0.013234:0.013234:0.005189:0.013115:0.011901:0.006617:0.013234:0.007998:0.013234:0.006617:0.005284:0.005284:0.013234:0.006522:0.005284:0.013234:0.006617:0.013068:0.013115:0.007926:0.013282:0.013234:0.013139:0.013234:0.013234:0.005284:0.013139:0.011901:0.006617:0.005284:0.011901:0.006474:0.013234:0.013234:0.013234:0.007926:0.013234:0.005284:0.013234:0.013234:0.005165:0.011901:0.013306:0.005284:0.006617
syndromes associated disorders in Malaysia   :@0.314899:0.916556:0.800754:0.916556:0.800754:0.897789:0.314899:0.897789:0.011901:0.011901:0.013234:0.013234:0.007926:0.013234:0.019828:0.013068:0.011901:0.006617:0.013115:0.011901:0.011901:0.013234:0.011973:0.005141:0.013234:0.006617:0.013234:0.013234:0.006617:0.013234:0.005094:0.011901:0.013234:0.007926:0.013234:0.013139:0.007831:0.011901:0.006617:0.005284:0.013234:0.006617:0.019828:0.013234:0.005094:0.013234:0.011901:0.011901:0.005284:0.013234:0.006617:0.006611:0.006617
 :@0.906214:0.895693:0.912832:0.895693:0.912832:0.876927:0.906214:0.876927:0.006617